Dimethylarginines in patients with type 2 diabetes mellitus: relation with the glycaemic control

Ayten Can; Seldag Bekpinar; Figen Gurdol; Yıldız Tutuncu; Yesim Unlucerci; Nevin Dinccag

doi:10.1016/j.diabres.2011.08.008

Dimethylarginines in patients with type 2 diabetes mellitus: relation with the glycaemic control

Diabetes Res Clin Pract. 2011 Dec;94(3):e61-4. doi: 10.1016/j.diabres.2011.08.008. Epub 2011 Sep 1.

Authors

Ayten Can¹, Seldag Bekpinar, Figen Gurdol, Yıldız Tutuncu, Yesim Unlucerci, Nevin Dinccag

Affiliation

¹ Department of Biochemistry, Istanbul Faculty of Medicine, Istanbul University, Capa 34093, Istanbul, Turkey.

PMID: 21889812
DOI: 10.1016/j.diabres.2011.08.008

Abstract

We tested the relationship between plasma levels of dimethylarginines (ADMA and SDMA) and glycaemic control in 43 type 2 diabetic patients. Type 2 diabetics with poor glycaemic control (HbA1c>6.5) had significantly lower SDMA and higher ADMA concentrations than those with well-controlled glycaemia (HbA1c<6.5).

Publication types

Comparative Study
Research Support, Non-U.S. Gov't

MeSH terms

Arginine / analogs & derivatives*
Arginine / blood
Blood Glucose / analysis*
Case-Control Studies
Diabetes Complications / blood*
Diabetes Mellitus, Type 2 / physiopathology*
Female
Glycated Hemoglobin / analysis*
Glycemic Index
Humans
Male
Prognosis

Substances

Blood Glucose
Glycated Hemoglobin A
dimethylarginine
Arginine